Page 38 - TD-1-1

Tumor Discovery The mechanism of cancer-related cognitive decline

induces protein oxidation in plasma and TNF-α elevation storage from single cells. ACS Chem Neurosci, 10(4):
in macrophage culture: Insights into mechanisms of 2060–2069.
neurotoxicity following doxorubicin chemotherapy. Cancer https://doi.org/10.1021/acschemneuro.8b00714
Lett, 367(2): 157–161.
68. Gervais NJ, Remage-Healey L, Starrett JR, et al., 2019,
https://doi.org/10.1016/j.canlet.2015.07.023 Adverse effects of aromatase inhibition on the brain and
58. Lv L, Mao S, Dong H, et al., 2020, Pathogenesis, assessments, behavior in a nonhuman primate. J Neurosci, 39(5): 918–928.
and management of chemotherapy-related cognitive https://doi.org/10.1523/jneurosci.0353-18.2018
impairment (CRCI): An updated literature review. J Oncol,
2020: 3942439. 69. Joly F, Heutte N, Duclos B, et al., 2016, Prospective evaluation of
the impact of antiangiogenic treatment on cognitive functions
https://doi.org/10.1155/2020/3942439 in metastatic renal cancer. Eur Urol Focus, 2(6): 642–649.
59. Ren X, St Clair DK, Butterfield DA, 2017, Dysregulation https://doi.org/10.1016/j.euf.2016.04.009
of cytokine mediated chemotherapy induced cognitive
impairment. Pharmacol Res, 117: 267–273. 70. Mulder SF, Bertens D, Desar IM, et al., 2014, Impairment
of cognitive functioning during sunitinib or sorafenib
https://doi.org/10.1016/j.phrs.2017.01.001 treatment in cancer patients: A cross sectional study. BMC
60. Gibson EM, Monje M, 2019, Emerging mechanistic Cancer, 14: 219.
underpinnings and therapeutic targets for chemotherapy- https://doi.org/10.1186/1471-2407-14-219
related cognitive impairment. Curr Opin Oncol, 31(6): 531–539.
71. Abdel-Aziz AK, Mantawy EM, Said RS, et al., 2016, The
https://doi.org/10.1097/cco.0000000000000578 tyrosine kinase inhibitor, sunitinib malate, induces cognitive
61. Lyon D, Elmore L, Aboalela N, et al., 2014, Potential impairment in vivo via dysregulating VEGFR signaling,
epigenetic mechanism(s) associated with the persistence apoptotic and autophagic machineries. Exp Neurol,
of psychoneurological symptoms in women receiving 283(Pt A): 129–141.
chemotherapy for breast cancer: A hypothesis. Biol Res Nurs, 72. Joly F, Castel H, Tron L, et al., 2020, Potential effect of
16(2): 160-174. immunotherapy agents on cognitive function in cancer
62. Cardoso S, Santos RX, Carvalho C, et al., 2008, Doxorubicin patients. J Natl Cancer Inst, 112(2): 123–127.
increases the susceptibility of brain mitochondria to Ca( )- https://doi.org/10.1093/jnci/djz168
2+
induced permeability transition and oxidative damage. Free
Radic Biol Med, 45(10): 1395–1402. 73. Greenbaum U, Kebriaei P, Srour SA, et al., 2021, Chimeric
antigen receptor T-cell therapy toxicities. Br J Clin
63. Uzar E, Koyuncuoglu HR, Uz E, et al., 2006, The activities Pharmacol, 87(6): 2414–2424.
of antioxidant enzymes and the level of malondialdehyde
in cerebellum of rats subjected to methotrexate: Protective https://doi.org/10.1111/bcp.14403
effect of caffeic acid phenethyl ester. Mol Cell Biochem, 74. Cuzzubbo S, Belin C, Chouahnia K, et al., 2018, Assessing
291(1-2): 63–68. cognitive function in patients treated with immune
https://doi.org/10.1007/s11010-006-9196-5 checkpoint inhibitors: A feasibility study. Psychooncology,
27(7): 1861–1864.
64. Cauli O, 2021, Oxidative stress and cognitive alterations
induced by cancer chemotherapy drugs: A scoping review. https://doi.org/10.1002/pon.4725
Antioxidants (Basel), 10(7): 1116. 75. Neelapu SS, Locke FL, Bartlett NL, et al., 2017, Axicabtagene
https://doi.org/10.3390/antiox10071116 ciloleucel CAR T-cell therapy in refractory large B-cell
lymphoma. N Engl J Med, 377(26): 2531–2544.
65. Nyunt T, Britton M, Wanichthanarak K, et al., 2019,
Mitochondrial oxidative stress-induced transcript variants https://doi.org/10.1056/nejmoa1707447
of ATF3 mediate lipotoxic brain microvascular injury. Free 76. Chen H, Wang F, Zhang P, et al., 2019, Management of
Radic Biol Med, 143: 25–46. cytokine release syndrome related to CAR-T cell therapy.
https://doi.org/10.1016/j.freeradbiomed.2019.07.024 Front Med, 13(5): 610–617.
66. Jebahi F, Sharma S, Bloss JE, et al., 2021, Effects of tamoxifen https://doi.org/10.1007/s11684-019-0714-8
on cognition and language in women with breast cancer: 77. Santomasso BD, Park JH, Salloum D, et al., 2018, Clinical
A systematic search and a scoping review. Psychooncology, and biologic correlates of neurotoxicity associated with CAR
30(8): 1262–1277. T cell therapy in patients with B-cell acute lymphoblastic
leukemia. Cancer Discov, 8(8): 958–971.
https://doi.org/10.1002/pon.5696
https://doi.org/10.1158/2159-8290.cd-17-1319
67. Taleat Z, Larsson A, Ewing AG, 2019, Anticancer drug
tamoxifen affects catecholamine transmitter release and 78. Pazzaglia S, Briganti G, Mancuso M, et al., 2020,

Volume 1 Issue 1 (2022) 10 https://doi.org/10.36922/td.v1i1.46